Summary
Machine-generated summaryThis Finnish procurement covers aflibercept medicines for injection into the eye's vitreous cavity, belonging to ATC group S01LA05. The products must be authorised for sale in Finland for use in adults and commercially available in Finland by 1.1.2027. The supply period runs from 1.1.2027 to 31.12.2027. No estimated contract value, buyer details, submission deadline, supplier eligibility criteria or procedure type are stated in the notice, so interested suppliers should consult the full tender documents for those details before preparing a bid.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profileRecent awards
- Pharmaceutical products - Medicines and comparable products for the procurement period 1.1.2026-31.12.2027
- Suomi - Farmaseuttiset tuotteet - Orfiril-injektioneste ajalle 1.9.2026-31.12.2027 Pohteen lääkehankintarenkaalle
- Suomi - Farmaseuttiset tuotteet - Nusinerseeni (Spinraza 28mg ja 50mg)-valmisteiden valinta ajalle 15.5.2026-31.12.2027 Pohteen lääkehankintarenkaalle
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,063,485
- Buyer track record on Aperlena
- 9 notices tracked · 7 awarded
- €829,143 in awarded contracts
Never miss a tender like this
37 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.
Set up my alert